QLT’s BPH Drug Fails To Show Efficacy In Phase II

Feb. 17, 2006

By Jennifer Boggs

Australia’s G2 Enters Novo Deal Valued At Up To $102M

Feb. 16, 2006

By Jennifer Boggs

Australia’s G2 Enters Novo Deal Valued At Up To $102M

Feb. 16, 2006

By Jennifer Boggs

YM’s Direct Offering Raises $40M For Drug Development

Feb. 15, 2006

By Jennifer Boggs

YM’s Direct Offering Raises $40M For Drug Development

Feb. 15, 2006

By Jennifer Boggs

Replidyne Gets $50M Up Front Through Forest Collaboration

Feb. 14, 2006

By Jennifer Boggs

Replidyne Gets $50M Up Front Through Forest Collaboration

Feb. 14, 2006

By Jennifer Boggs

After First Product Approval, BioMimetic Seeks $50M IPO

Feb. 13, 2006

By Jennifer Boggs

Private Placement Adding $27M To VaxGen’s Anthrax Drug Work

Feb. 13, 2006

By Jennifer Boggs

Private Placement Adding $27M To VaxGen’s Anthrax Drug Work

Feb. 13, 2006

By Jennifer Boggs